Adjuvant cardioprotection in cardiac surgery: update.

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Cellular Biology

Background:

• Increasingly complex cardiac surgeries involve high-risk patients with advanced age and comorbidities.
• Reperfusion injury, a significant complication post-cardiac surgery, leads to myocardial dysfunction and mortality.
• Existing cardioprotective strategies often fall short in clinical trials due to limitations in cellular protection mechanisms.

Purpose of the Study:

• To explore the therapeutic potential of myocardial conditioning in mitigating reperfusion injury during cardiac surgery.
• To review the mechanisms underlying reperfusion injury and myocardial conditioning.
• To identify challenges in translating preclinical cardioprotective findings into clinical practice.

Main Methods:

• Review of extensive preclinical research on reperfusion injury and myocardial conditioning mechanisms.
• Analysis of the limitations of current cardioprotective therapies in clinical trials.
• Discussion of the evolutionary basis for the robustness of cellular protection mechanisms.

Main Results:

• Myocardial conditioning, induced by brief ischemia-reperfusion episodes, shows promise for intraoperative myocardial protection.
• Pharmacological agents mimicking ischemic conditioning are under investigation.
• Despite decades of research, most cardioprotective therapies have failed in Phase III clinical trials.

Conclusions:

• Myocardial conditioning and related therapies hold therapeutic potential for reducing cardiac surgery complications.
• The limited robustness of evolutionary young cellular protection mechanisms hinders the efficacy of cardioprotective strategies.
• Resolving methodological issues and clinical translation challenges is crucial for the successful implementation of these treatments.